Stockholders' Equity |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stockholders' Equity | Stockholders’ Equity The authorized shares of the Company consist of an unlimited number of common and preferred shares, both without par value. All proceeds received for issuances of common shares are attributed to common shares on the Company’s unaudited consolidated balance sheets. During the three months ended June 30, 2026, the Company issued 34,446 common shares upon the settlement of restricted stock units ("RSUs"). In connection with the settlement of the RSUs, the Company reclassified $58 from additional paid-in capital to common stock. During the three months ended June 30, 2025, the Company issued 672,043 common shares on the exercise of stock options, for gross proceeds of $549. In connection with the stock options exercised, the Company reclassified $444 from additional paid in capital to common shares. During the six months ended June 30, 2026, the Company issued: i)34,446 common shares upon the settlement of RSUs. In connection with the settlement of the RSUs, the Company reclassified $58 from additional paid-in capital to common stock. ii)6,786,495 total common shares on the exercise of warrants. 6,510,400 common shares were issued for gross proceeds of $22,829, which included $5,031 reclassified from additional paid-in capital to common shares. Additionally, 276,095 common shares were issued on cashless exercises of 3,667,002 warrants, which included $3,636 reclassified from additional paid-in capital to common shares. iii)75,234 common shares on the exercise of stock options, for gross proceeds of $149, which included $111 reclassified from additional paid-in capital to common shares. During the six months ended June 30, 2025, the Company issued: i)90,000 common shares on the exercise of warrants, for gross proceeds of $236, which included $66 reclassified from additional paid-in capital to common shares. ii)853,376 common shares on the exercise of stock options, for gross proceeds of $690, which included $544 reclassified from additional paid-in capital to common shares. Share Purchase Warrants A summary of the status of the Company’s warrants as of June 30, 2026, and changes during the six months ended are as follows:
As of June 30, 2026, there were no share purchase warrants outstanding.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||